In this context, it is conceivable that early-life ETS enhances the effect size of the risk alleles at TNS1 and NRXN1, while conversely, these genetic variants may shape the extent to which ETS exposure increases the risk of eczema-associated asthma. The gene discussed is TNS1; the disease is Eczematoid dermatitis.